Has The COVID-19 Pandemic Affected Injury in Football?

March 1, 2022 updated by: Nurhayat KORKMAZ, Karadeniz Technical University

Has The COVID-19 Pandemic Affected Injury in Football? Example of a Professional Football Team

This study aims to compare the injuries that occurred in the football players after the isolation and lack of training caused by New Coronavirus Disease (COVID-19), with the previous season, based on the example of a professional football team in Turkey.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

This study aims to compare the injuries that occurred in the football players who faced an intense match tempo after the isolation and lack of training caused by COVID-19, as well as the stress and uncertainty, with the previous season, based on the example of a professional football team in Turkey. Injury follow-up data were examined.

Study Type

Observational

Enrollment (Actual)

24

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Trabzon, Turkey, 61000
        • Karadeniz Technical University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Sampling Method

Probability Sample

Study Population

Participants consist of professional football players who have a contract with the A team.

Description

Inclusion Criteria:

  • Having a musculoskeletal injury during the official match or team training in the 2019-2020 or 2020-2021 season

Exclusion Criteria:

  • Signing a contract with Trabzonspor A Team in the 2020-2021 season

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
2019-2020 season
Injuries in the first 26 games of 2019-2020
No intervention was made.
2020-2021 season
Injuries in the first 26 games of 2020-2021 in the new post-COVID season
No intervention was made.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of injuries
Time Frame: Change of data in the first 26 matches of the 2019-2020 and 2020-2021 seasons
The number of injuries in the two seasons was recorded separately.
Change of data in the first 26 matches of the 2019-2020 and 2020-2021 seasons
Injury time
Time Frame: Change of data in the first 26 matches of the 2019-2020 and 2020-2021 seasons
Training injuries, Match injuries
Change of data in the first 26 matches of the 2019-2020 and 2020-2021 seasons
Injury severity
Time Frame: Change of data in the first 26 matches of the 2019-2020 and 2020-2021 seasons
Minor, moderate, major
Change of data in the first 26 matches of the 2019-2020 and 2020-2021 seasons
Injury type
Time Frame: Change of data in the first 26 matches of the 2019-2020 and 2020-2021 seasons
Sprain, strain, fracture, contision, other
Change of data in the first 26 matches of the 2019-2020 and 2020-2021 seasons
Injury location
Time Frame: Change of data in the first 26 matches of the 2019-2020 and 2020-2021 seasons
Foot, ankle, calf, knee, thigh, hip, groin, lumbal
Change of data in the first 26 matches of the 2019-2020 and 2020-2021 seasons
Injured tissue
Time Frame: Change of data in the first 26 matches of the 2019-2020 and 2020-2021 seasons
muscle, tendon, tendon bone junction, capsule, ligament, bone, aponeurosis, meniscus
Change of data in the first 26 matches of the 2019-2020 and 2020-2021 seasons
Injured side
Time Frame: Change of data in the first 26 matches of the 2019-2020 and 2020-2021 seasons
Left, right
Change of data in the first 26 matches of the 2019-2020 and 2020-2021 seasons
Injury mechanism
Time Frame: Change of data in the first 26 matches of the 2019-2020 and 2020-2021 seasons
noncontact, contact
Change of data in the first 26 matches of the 2019-2020 and 2020-2021 seasons
Rule violation
Time Frame: Change of data in the first 26 matches of the 2019-2020 and 2020-2021 seasons
Opponent, no
Change of data in the first 26 matches of the 2019-2020 and 2020-2021 seasons
Recurrence
Time Frame: Change of data in the first 26 matches of the 2019-2020 and 2020-2021 seasons
Yes, no
Change of data in the first 26 matches of the 2019-2020 and 2020-2021 seasons

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Training
Time Frame: Change of data in the first 26 matches of the 2019-2020 and 2020-2021 seasons
The number of days away from training
Change of data in the first 26 matches of the 2019-2020 and 2020-2021 seasons
Missed Matches
Time Frame: Change of data in the first 26 matches of the 2019-2020 and 2020-2021 seasons
Number of official matches missed
Change of data in the first 26 matches of the 2019-2020 and 2020-2021 seasons

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 26, 2021

Primary Completion (Actual)

May 30, 2021

Study Completion (Actual)

June 30, 2021

Study Registration Dates

First Submitted

February 28, 2022

First Submitted That Met QC Criteria

March 1, 2022

First Posted (Actual)

March 2, 2022

Study Record Updates

Last Update Posted (Actual)

March 2, 2022

Last Update Submitted That Met QC Criteria

March 1, 2022

Last Verified

March 1, 2022

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe